Minus the Waksal brothers, ImClone Systems Inc. and Bristol-Myers Squibb Co. forged ahead and, as planned, filed a biologics license application for the investigational IgG1 monoclonal antibody ...

Johnson & Johnson’s Janssen unit has filed a rolling submission for its multiple myeloma CAR-T ciltacabtagene autoleucel (cilta-cel) to the FDA, in hot pursuit of Bristol-Myers Squibb’s delayed rival ...